Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes
K. Zhan et al.
Summary: Glycemic control is significantly associated with both short-term and long-term outcomes in COVID-19 patients with type 2 diabetes. Well-controlled blood glucose can reduce the risk of death, intensive care unit admission, mechanical ventilation, disease progression, and composite outcome. It also decreases the risk of respiratory sequelae.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2022)
Letter
Endocrinology & Metabolism
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes
G. Rayman et al.
DIABETIC MEDICINE (2021)
Article
Public, Environmental & Occupational Health
Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study
Ahmed A. Alrashed et al.
Summary: The use of ACEI/ARB medications in severe COVID-19 patients is associated with an increased risk of developing critical or severe COVID-19, admission to the intensive care unit, and requiring noninvasive ventilation. This risk is particularly evident in patients with diabetes, hypertension, and/or renal disease.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Share Paper
